Ensysce Biosciences Income Statement (2020-2025) | ENSCW

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 1.82M0.83M0.42M0.25M0.44M1.20M1.64M0.60M0.21M0.28M1.43M0.79M0.49M0.44M0.52M0.31M0.18M3.42M1.30M1.32M1.37M0.49M
Operating items
Research & Development 1.40M0.89M1.25M0.28M0.46M1.71M2.19M3.14M5.31M4.76M6.44M1.80M1.64M1.91M2.23M0.78M0.95M1.69M3.80M1.89M1.92M2.95M
Selling, General & Administrative 0.28M0.34M0.26M0.49M0.39M16.37M1.45M2.27M1.95M1.69M1.19M1.55M1.14M1.23M1.44M1.37M1.19M1.08M1.08M1.40M1.20M1.28M
Operating Expenses 1.69M1.23M1.51M0.77M0.86M18.09M3.64M5.41M7.26M6.44M7.63M3.35M2.78M3.14M3.67M2.15M2.14M2.77M4.88M3.29M3.12M4.23M
Operating Income 0.14M-0.40M-1.09M-0.52M-0.41M-16.89M-2.01M-4.80M-7.06M-6.16M-6.20M-2.56M-2.29M-2.71M-3.16M-1.84M-1.96M0.64M-3.58M-1.97M-1.75M-3.74M
EBIT 0.14M-0.40M-1.09M-0.52M-0.41M-16.89M-2.01M-4.80M-7.06M-6.16M-6.20M-2.56M-2.29M-2.71M-3.16M-1.84M-1.96M0.64M-3.58M-1.97M-1.75M-3.74M
Non-operating items
Other Non Operating Income -0.04M0.71M0.06M0.01M0.00M0.01M0.07M0.01M0.01M0.01M-0.01M-0.03M0.01M0.01M0.03M0.02M0.02M0.02M
Non Operating Income -0.85M1.96M1.11M-0.39M-0.54M-0.31M-8.03M3.85M-0.87M-3.69M0.79M0.37M0.05M0.02M-0.35M-1.27M-0.01M0.02M0.01M0.02M0.02M0.02M
Net income details
EBT -0.06M-0.62M-1.34M-0.87M-1.32M-16.91M-2.02M-4.82M-7.09M-6.17M-6.25M-2.56M-2.29M-2.71M-3.50M-3.09M-1.98M0.64M-3.59M-1.97M-1.75M-3.75M
Profit After Tax -0.71M1.57M0.02M-0.91M-0.96M-17.20M-10.04M-0.95M-7.92M-9.86M-5.48M-2.19M-2.24M-2.69M-3.50M-3.12M-1.97M0.66M-3.56M-1.95M-1.73M-3.73M
Income from Non-Controlling Interests -0.00M-0.02M-0.20M-0.00M-0.02M-0.04M-214.00182.00-0.03M-0.02M0.01M-0.00M-0.01M-0.00M-965.00-74.00-166.00
Income from Continuing Operations -0.06M-0.62M-1.34M-0.87M-1.32M-16.91M-2.02M-4.82M-7.09M-6.17M-6.25M-2.56M-2.29M-2.71M-3.50M-3.09M-1.98M0.64M-3.59M-1.97M-1.75M-3.75M
Consolidated Net Income -0.06M-0.62M-1.34M-0.87M-1.32M-16.91M-2.02M-4.82M-7.09M-6.17M-6.25M-2.56M-2.29M-2.71M-3.50M-3.09M-1.98M0.64M-3.59M-1.97M-1.75M-3.75M
Income towards Parent Company -0.06M-0.62M-1.34M-0.87M-1.32M-16.91M-2.02M-4.82M-7.09M-6.17M-6.25M-2.56M-2.29M-2.71M-3.50M-3.09M-1.98M0.64M-3.59M-1.97M-1.75M-3.75M
Preferred Dividend Payments 0.72M0.10M0.06M0.03M0.01M0.00M899.00290.00
Net Income towards Common Stockholders -0.06M1.57M0.21M-0.91M-0.94M-17.16M-10.84M-1.67M-8.00M-9.90M-5.52M-2.20M-2.24M-2.69M-3.50M-3.12M-1.97M0.66M-3.56M-1.95M-1.73M-3.73M
Additional items
EPS (Basic) -0.040.100.01-0.06-0.06-14.15-9.33-14.66-56.49-61.58-30.69-2.08-0.98-0.87-23.22-8.21-3.351.00-5.11-1.39-0.79-1.29
EPS (Weighted Average and Diluted) 0.090.01-0.71-0.54-56.49-61.58-30.69-2.08-0.98-0.87-23.22-8.21-3.351.00-5.11-1.39-0.79-1.29
Shares Outstanding (Weighted Average) 7.07M15.77M15.77M15.77M15.83M16.05M1.21M1.01M0.11M0.14M0.16M0.18M1.05M2.27M3.09M0.15M0.38M0.59M0.66M0.70M1.40M2.20M2.89M
Shares Outstanding (Diluted Average) 16.85M16.51M24.26M20.16M0.14M0.16M0.18M1.05M2.27M3.09M0.15M0.38M0.59M0.66M0.70M1.40M2.20M2.89M
EBITDA 0.14M-0.40M-1.09M-0.52M-0.41M-16.89M-2.01M-4.80M-7.06M-6.16M-6.20M-2.56M-2.29M-2.71M-3.16M-1.84M-1.96M0.64M-3.58M-1.97M-1.75M-3.74M
Interest Expenses 0.20M0.22M0.25M0.35M0.91M0.02M0.01M0.02M0.04M0.00M0.05M0.00M0.01M0.34M1.25M0.03M0.00M0.01M0.00M0.00M0.01M